Loading…

Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection: A phase II study following the learning curve

Background and Objectives A preliminary study on the use of laparoscopy‐assisted approach to treat gastric carcinoma resulted in higher morbidity. Study Design A prospective phase II study of laparoscopy‐assisted distal gastrectomy (LADG) was performed for patients with preoperative diagnosis of T1...

Full description

Saved in:
Bibliographic Details
Published in:Journal of surgical oncology 2005-07, Vol.91 (1), p.26-32
Main Authors: Fujiwara, Michitaka, Kodera, Yasuhiro, Miura, Shinichi, Kanyama, Yasuaki, Yokoyama, Hiroyuki, Ohashi, Norifumi, Hibi, Kenji, Ito, Katsuki, Akiyama, Seiji, Nakao, Akimasa
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and Objectives A preliminary study on the use of laparoscopy‐assisted approach to treat gastric carcinoma resulted in higher morbidity. Study Design A prospective phase II study of laparoscopy‐assisted distal gastrectomy (LADG) was performed for patients with preoperative diagnosis of T1 N0 stage cancer located in the lower or middle‐third stomach. Bleeding amount, operating time, mortality, morbidity, and the number of lymph node retrieval were recorded and compared with the preliminary series reported previously by the same authors. Results Between 2000 and 2002, 47 patients were accrued. The mean blood loss and postoperative hospital stay were significantly decreased compared with the previous series, whereas the operating time was not. There were no in‐hospital deaths, with the incidence of anastomotic leakage significantly decreased. All patients remain disease‐free to date. Conclusions LADG can be performed safely and morbidity, no longer, is a drawback by experienced hands that have reached plateau of the learning curve, although it remains a time‐consuming procedure. Its application to gastric cancer surgery is feasible for early stage cancer, and its applicability to the treatment of T2 stage cancer will be the next issue to be explored. J. Surg. Oncol. 2005;91:26–32. © 2005 Wiley‐Liss, Inc.
ISSN:0022-4790
1096-9098
DOI:10.1002/jso.20166